In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles

Bioconjugate Chemistry

Volumn 22, Issue 12, 2011, Pages 2568-2572

  Jin, Juyoun ^a,b   Bae, Ki Hyun ^d   Yang, Heekyoung ^a,b   Lee, Se Jeong ^a,b   Kim, Hyein ^e   Kim, Yonghyun ^a,b   Joo, Kyeung Min ^b,c   Seo, Soo Won ^a   Park, Tae Gwan ^a,d   Nam, Do Hyun ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^e Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; CELL PROLIFERATION; NANOPARTICLES; RNA; TUMORS;

BRAIN TUMORS; CATIONIC SOLID LIPID NANOPARTICLES; GENES EXPRESSION; GLIOBLASTOMAS; IN-VIVO; LIPID NANOPARTICLES; RNA INTERFERENCE; SMALL INTERFERING RNA; TARGET CELLS; TARGET TISSUES;

GENE EXPRESSION;

LOW DENSITY LIPOPROTEIN; SCATTER FACTOR RECEPTOR; SMALL INTERFERING RNA; SOLID LIPID NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; TUMOR XENOGRAFT;

MUS;

EID: 84555220669     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc200406n     Document Type: Article

References (10)

1. Rajadhyaksha, M., Boyden, T., Liras, J., El-Kattan, A., and Brodfuehrer, J. (2011) Current advances in delivery of biotherapeutics across the blood-brain barrier Curr. Drug Discovery Technol. 8, 87-101
2. Kim, H. R., Kim, I. K., Bae, K. H., Lee, S. H., Lee, Y., and Park, T. G. (2008) Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA Mol. Pharm. 5, 622-31
3. Hannon, G. J. and Rossi, J. J. (2004) Unlocking the potential of the human genome with RNA interference Nature 431, 371-8 (Pubitemid 39265678)
4. Oishi, M., Nagasaki, Y., Itaka, K., Nishiyama, N., and Kataoka, K. (2005) Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells J. Am. Chem. Soc. 127, 1624-5 (Pubitemid 40229133)
5. Lu, P. Y., Xie, F., and Woodle, M. C. (2005) In vivo application of RNA interference: from functional genomics to therapeutics Adv. Genet. 54, 117-42
6. Kim, S. H., Mok, H., Jeong, J. H., Kim, S. W., and Park, T. G. (2006) Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate Bioconjugate Chem. 17, 241-4 (Pubitemid 43157607)
7. Chung, N. S. and Wasan, K. M. (2004) Potential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake Adv. Drug Delivery Rev. 56, 1315-34 (Pubitemid 38510476)
8. Kim, S. H., Jeong, J. H., Lee, S. H., Kim, S. W., and Park, T. G. (2006) PEG conjugated VEGF siRNA for anti-angiogenic gene therapy J. Controlled Release 116, 123-9 (Pubitemid 44854271)
9. Kong, D. S., Song, S. Y., Kim, D. H., Joo, K. M., Yoo, J. S., Koh, J. S., Dong, S. M., Suh, Y. L., Lee, J. I., Park, K., Kim, J. H., and Nam, D. H. (2009) Prognostic significance of c-Met expression in glioblastomas Cancer 115, 140-8
10. Grzelinski, M., Urban-Klein, B., Martens, T., Lamszus, K., Bakowsky, U., Hobel, S., Czubayko, F., and Aigner, A. (2006) RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts Hum. Gene Ther. 17, 751-66 (Pubitemid 44100720)